Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
2023 · New England Journal of Medicine · 718 citations
https://doi.org/10.1056/nejmoa2216334
F
Francesco Raspagliesi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
752
Papers
22.1K
Citations
69
h-index
337
i10-index
Francesco Raspagliesi is an academic researcher from University of Milan. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Ovarian cancer diagnosis and treatment & Cervical Cancer and HPV Research. The author has an h-index of 69, co-authored 640 publications.
ORCID: 0000-0001-8953-1657Papers by this author
worksEffect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
2021 · The Lancet Oncology · 282 citations
https://doi.org/10.1016/s1470-2045(21)00493-9
Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study
2020 · Journal of Clinical Oncology · 222 citations
https://doi.org/10.1200/jco.20.01933
Delaying surgery for patients with a previous SARS-CoV-2 infection
2020 · British journal of surgery · 143 citations
https://doi.org/10.1002/bjs.12050
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial
2020 · European Journal of Cancer · 107 citations
https://doi.org/10.1016/j.ejca.2020.06.034
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy
2019 · Proceedings of the National Academy of Sciences · 93 citations
https://doi.org/10.1073/pnas.1911385116
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat